Literature DB >> 7972929

Coupling of pancreatic gastrin/cholecystokinin-B (G/CCKB) receptors to phospholipase C and protein kinase C in AR4-2J tumoral cells.

C Seva1, J L Scemama, L Pradayrol, P D Sarfati, N Vaysse.   

Abstract

Gastrin and cholecystokinin (CCK) have proven trophic effects on the gut. We have previously demonstrated that these peptides stimulate an early event in cellular proliferation, namely ornithine decarboxylase activity (ODC), in a rat exocrine pancreatic cell line AR4-2J. Furthermore, this effect is mediated through a G/CCKB receptor. Thus, in the present study we sought to examine the signal transduction mechanisms linked to the G/CCKB receptor occupancy. Both gastrin and CCK induced a rapid (maximum at 40 s) increase in inositol triphosphates (InsP3) and diacylglycerol (DAG) formation in a dose-dependent manner (EC50 = 5.6 nM) that quickly returned to baseline. Although InsP3 levels remained at baseline, DAG levels demonstrated a second gradual increase that was maximal at 15 min. CCK/gastrin efficiency to stimulate DAG and InsP3 formation (EC50 = 5.6 nM) could be correlated to the G/CCKB receptor occupancy, suggesting a coupling of this receptor to phospholipase C. To examine the involvement of protein kinase C (PKC) activation in the increase in ODC activity, we stimulated the AR4-2J cells with the phorbol ester TPA and observed an increase in ODC activity with a maximal effect at 100 nM. TPA stimulation of ODC activity was completely abolished by the PKC inhibitor staurosporine (50 nM). However, 50 nM staurosporine inhibited only 65% of the gastrin and CCK induced increase in ODC activity suggesting that a portion of the G/CCKB receptor-mediated increase in ODC activity is PKC independent.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7972929     DOI: 10.1016/0167-0115(94)90018-3

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  8 in total

1.  Dexamethasone-induced decrease in HMG-CoA reductase and protein-farnesyl transferase activities does not impair ras processing in AR 4-2J cells.

Authors:  M Lambert; N D Bui
Journal:  Mol Cell Biochem       Date:  1999-12       Impact factor: 3.396

2.  Thermodynamic analysis of ligands at cholecystokinin CCK2 receptors in rat cerebral cortex.

Authors:  E A Harper; S P Roberts; S B Kalindjian
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

3.  Gastrin and the neuropeptide PACAP evoke secretion from rat stomach histamine-containing (ECL) cells by stimulating influx of Ca2+ through different Ca2+ channels.

Authors:  E Lindström; L Eliasson; M Björkqvist; R Håkanson
Journal:  J Physiol       Date:  2001-09-15       Impact factor: 5.182

4.  CacyBP/SIP nuclear translocation induced by gastrin promotes gastric cancer cell proliferation.

Authors:  Hui-Hong Zhai; Juan Meng; Jing-Bo Wang; Zhen-Xiong Liu; Yuan-Fei Li; Shan-Shan Feng
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

5.  Ca2+ and protein kinase C-dependent mechanisms involved in gastrin-induced Shc/Grb2 complex formation and P44-mitogen-activated protein kinase activation.

Authors:  L Daulhac; A Kowalski-Chauvel; L Pradayrol; N Vaysse; C Seva
Journal:  Biochem J       Date:  1997-07-15       Impact factor: 3.857

Review 6.  The production and role of gastrin-17 and gastrin-17-gly in gastrointestinal cancers.

Authors:  Jeffrey Copps; Richard F Murphy; Sándor Lovas
Journal:  Protein Pept Lett       Date:  2009       Impact factor: 1.890

7.  Salt-inducible kinase 1 (SIK1) is induced by gastrin and inhibits migration of gastric adenocarcinoma cells.

Authors:  Linn-Karina M Selvik; Shalini Rao; Tonje S Steigedal; Ildri Haltbakk; Kristine Misund; Torunn Bruland; Wenche S Prestvik; Astrid Lægreid; Liv Thommesen
Journal:  PLoS One       Date:  2014-11-10       Impact factor: 3.240

8.  CacyBP/SIP promotes the proliferation of colon cancer cells.

Authors:  Huihong Zhai; Yongquan Shi; Xiong Chen; Jun Wang; Yuanyuan Lu; Faming Zhang; Zhengxiong Liu; Ting Lei; Daiming Fan
Journal:  PLoS One       Date:  2017-02-14       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.